Hematopoietic Stem Cell Transplant in MS: Third Study Reports Positive Results
Researchers in Italy released results from a randomized, controlled, multicenter phase 2 trial of autologous hematopoietic stem cell transplantation. Their regimen led to significant reduction in T2-weighted lesions and annualized relapse rate.
Researchers in Italy released results from a randomized, controlled, multicenter phase 2 trial of autologous hematopoietic stem cell transplantation. Their regimen led to significant reduction in T2-weighted lesions and annualized relapse rate.
The battle of the conditioning regimens rages on as yet another article boasting successful results from...
Clinical Research